Neonatal abstinence syndrome (NAS) is a result of the sudden discontinuation of fetal
exposure to substances that were used or abused by the mother during pregnancy …

Neonates exposed prenatally to opioids will often develop a collection of withdrawal signs
known as neonatal abstinence syndrome (NAS). The incidence of NAS has substantially …

Neonatal abstinence syndrome (NAS) is suffered by infants withdrawing from substances on
which they have become physically dependent after in utero exposure. They may require …

Background Neonatal abstinence syndrome (NAS) occurs following prenatal opioid
exposure. It is characterized by signs and symptoms indicating central nervous system …

Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants
develop after intrauterine maternal drug exposure. All infants with documented in utero …

Aims: To determine the monitoring and treatment of neonatal abstinence syndrome (NAS) in
neonatal intensive care units (NICUs) following opiate or polydrug exposure in utero …

OBJECTIVES: Neonatal abstinence syndrome (NAS) is a growing problem and poses a
significant burden on the health care system. The traditional Finnegan Neonatal Abstinence …

Although a statement on Neonatal Drug Withdrawal was published in 1998 by the American
Academy of Pediatrics, pharmacologic management of neonatal abstinence syndrome …

Aim: To ascertain the present management of neonatal abstinence syndrome (NAS) in
neonatal units in the United Kingdom (UK) and Ireland. Methods: Postal questionnaire to …

Neonatal abstinence syndrome (NAS) refers to a constellation of signs that are present in
some newborn infants resulting from the abrupt cessation of passive transfer of maternal …